Revolution Medicines, Inc. (RVMD)

NASDAQ: RVMD · IEX Real-Time Price · USD

37.38

-1.43 (-3.68%)

At close: Jul 2, 2024, 4:00 PM

37.75

+0.37 (0.99%)

After-hours: Jul 2, 2024, 4:47 PM EDT

Revolution Medicines Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2017
Net Income	-436.37	-248.71	-187.09	-110.38	-61.9	Upgrade
Depreciation & Amortization	9.31	9.66	7.33	6.55	3.34	Upgrade
Share-Based Compensation	61.77	31.2	20.72	8.89	3.16	Upgrade
Other Operating Activities	14.71	-16.55	11.86	-7.34	-8.46	Upgrade
Operating Cash Flow	-350.57	-224.4	-147.18	-100.06	-49.62	Upgrade
Capital Expenditures	-7.73	-10.82	-6.53	-2.93	-2.39	Upgrade
Change in Investments	-334.87	-13.3	-135.59	-231.3	-105.58	Upgrade
Other Investing Activities	-	-	-	-	6	Upgrade
Investing Cash Flow	-342.6	-24.12	-142.12	-234.23	-101.97	Upgrade
Share Issuance / Repurchase	392.39	301.39	294.6	422.78	0.23	Upgrade
Other Financing Activities	836.81	0.04	-0.42	-	98.43	Upgrade
Financing Cash Flow	1,229	301.43	294.18	422.78	98.66	Upgrade
Net Cash Flow	536.03	52.92	4.88	88.48	-52.93	Upgrade
Free Cash Flow	-358.3	-235.22	-153.71	-103	-52.01	Upgrade
Free Cash Flow Margin	-3094.14%	-664.83%	-522.99%	-239.62%	-103.93%	Upgrade
Free Cash Flow Per Share	-3.17	-2.92	-2.11	-1.88	-18.76	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).